Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fed Conditions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Objective:
Primary objective of the present study was to compare the single dose bioavailability of
Torrent's Rabeprazole Sodium Delayed Release Tablets 20 mg and Aciphex® Delayed Release
Tablets 20 mg (Reference, Eisai Inc., USA). Dosing periods were separated by a washout period
during fed study.
Study Design:
Open-Label, Randomised, two Period, two treatment, Crossover, Single-Dose Bioequivalence
Study